SHCbenzinga

Sotera Health Co Reaffirmed Its 2024 Guidance Of Net Revenue Growth Of 4%-6%; Adj. EPS Of $0.67-$0.75 Vs. $0.72 Est.; Sees Capital Expenditures Of $175M-$185M (Priro $205M-$225M)

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on November 5, 2024 by benzinga

    Sotera Health Co Reaffirmed Its 2024 Guidance Of Net Revenue Growth Of 4%-6%; Adj. EPS Of $0.67-$0.75 Vs. $0.72 Est.; Sees Capital Expenditures Of $175M-$185M (Priro $205M-$225M) | SHC Stock News | Candlesense